We operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment, complying with all applicable environmental regulations.
Our systems in place ensure the safe handling, movement, storage, recycling, reuse, or management of waste, air emissions and wastewater discharges, and prevent and mitigate accidental spills and release of fuels, raw materials, chemicals, intermediates, products, and other hazardous materials into the environment.
Among the activities dedicated to sustainability in the last three years on our sites, we can mention:
- high-efficiency cogenerators with reuse of thermal waste (obtaining white certificates);
- new thermal power plant for steam production (reduction of CO2 emissions and specific methane consumption);
- technologies to increase the degree of production containment to protect workers and the environment;
- distillation columns for solvent recovery (reduction of generated waste, reuse of solvents, circular);
- green chemistry projects for the replacement of chlorinated solvents and reduction of critical substances (particularly toxic, especially on new processes).
We provide all suppliers and external businesses with which we collaborate all over the world with a code of conduct document and a declaration of sustainability requirements: in a connected and interdependent world, individual action, however important, risks not being sufficient if it is not included in a dimension of shared practices. The document binds the signatories to guarantee our same standards in terms of environmental protection, treatment of workers and production safety certifications.
All new suppliers must sign the document and ensure our same level of sustainability at 360°. Our corporate guidelines provide that we will terminate the collaboration early in the case of failure to sign. Since adopting the document, we have already entered into more than 40 new sustainable trade agreements.
Every large company must take on a social responsibility, monitoring and responding to the economic, environmental and social expectations of all stakeholders: the "ethical" commitment has now entered directly into the so-called value chain, thus envisaging the use of new paths and competitive levers consistent with "sustainable development" for the community.
In fact, within a market that is both global and local, companies do not exist in their own right but are entities that live and act in a social fabric that includes various players, among which stands out a civil society that is very attentive towards entrepreneurial work.
The companies of the Olon Group established the Code of Ethics to define clearly and comprehensively the values which inspire the Group in reaching its goals. Compliance with it is essential for the proper operation, reliability, reputation, and image of the Group, which are fundamental elements for the success and for the current and future development of the businesses operated by Group Companies. Accordingly, the Group’s businesses must comply with the principles established in this Code of Ethics.
The Organisation and Management Model is a document that forms part of the supervisory infrastructure required under Legislative Decree 231/2001. The Model – providing it is adequately monitored –provides an indispensable guide for all our employees and collaborators. It sets out clear codes of conduct, control schemes and measures to prevent crimes and corrupt practices.
The major strength of an advanced company is represented by the people who make up its organization, and sustainability in its broadest meaning cannot fail to take this into account.
Successful research and development require the sharing of ideas and viewpoints between individuals: the more diverse the background, training and career pathways and experiences, the greater the possibilities will be to think “outside the box”, propose alternative solutions, and innovate.
We strive, thanks to a modern work environment, to create an organization that enables all individuals to reach their highest potential, investing in training and skills development, in job rotation programs and in talent development to grant both the people and the company sustainability and growth over time.
Our training projects, dedicated especially to young graduates in chemistry, engineering and pharmaceuticals, are combined with great attention to personnel safety, with an ambitious goal, already undertaken, of zero accidents, and the centrality of continuous training, which guarantees all employees an annual number of hours dedicated to it.
A profound technological revolution that questions production as we know it, must be carried on: the time frame to be taken into consideration will necessarily be longer, but required to develop more eco-friendly processes, which use fewer resources and produce less waste.
The approach to chemical synthesis has been more or less the same for a century: the reactions take place in large containers, which require significant amounts of energy to be cooled and heated. The challenge can only be to reduce energy consumption and the use of solvents that activate the reactions, but which must then be separated from the final product.
To obviate the important quantities of energy required by the reactions, in our production centers flow chemistry processes are being developed, generally referred to as continuous manufacturing, without interruption. No more batch reactions with loading and unloading phases, but always active microreactors, which treat less material, requiring much less energy for the cooling and heating procedures.
To reduce the use of solvents on the other hand, biocatalysis is well established within our reaction portfolio to develop innovative APIs: enzymes specifically created in the laboratory are able to transform a given starting material into the required finished product, in water at room temperature, without the need for special technologies.
In line with its long tradition, Olon Group’s target is to manufacture medicinal substances (intermediates and APIs for generic and the CMO/CDMO sector) to ensure they are fit for their intended uses and comply with the requirements of the Marketing Authorizations or Clinical Trial Authorizations.